Notable Labs Ltd (NTBL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NTBL | AMGN | REGN | VRTX | BMY |
| Company | Notable Labs Ltd | Amgen Inc | Regeneron Pharmaceuticals | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.5000 | 327.81 | 1,137.03 | 469.07 | 49.11 |
| High | 0.5050 | 330.65 | 1,143.19 | 476.11 | 49.19 |
| Low | 0.4800 | 320.30 | 1,113.24 | 460.69 | 48.25 |
| Last | 0.4949 | 329.98 | 1,141.45 | 474.74 | 48.59 |
| Change | +0.0149 | +1.05 | +5.10 | +3.96 | -0.69 |
| % Change | +3.10% | +0.32% | +0.45% | +0.84% | -1.40% |
| Volume | 18,200 | 1,711,000 | 481,900 | 947,500 | 8,425,300 |
| 20-Day Average Volume | 49,895 | 1,677,450 | 430,150 | 1,035,805 | 9,241,350 |
| Previous Close | 0.4800 | 328.93 | 1,136.35 | 470.78 | 49.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5545 | 327.38 | 1,174.48 | 479.64 | 48.99 |
| 20-Day Raw Stochastic | 22.45% | 65.91% | 28.80% | 35.52% | 44.11% |
| 20-Day Relative Strength | 41.54% | 53.57% | 51.78% | 47.88% | 54.20% |
| Weighted Alpha | -88.87 | +26.63 | +40.45 | +33.04 | -12.61 |
| Today's Opinion | 100% Sell | 88% Buy | 80% Buy | 40% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 80% Buy | 40% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 72% Buy | 100% Buy | 56% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.62% since 09/04/24 | -0.20% since 09/04/24 | -3.22% since 09/04/24 | -0.80% since 09/04/24 | -2.74% since 09/04/24 |
| Low | 0.4500 on 09/06/24 | 319.00 on 09/06/24 | 1,113.24 on 09/11/24 | 460.69 on 09/11/24 | 47.55 on 09/09/24 |
| High | 0.5280 on 09/05/24 | 331.86 on 09/05/24 | 1,175.16 on 09/05/24 | 477.73 on 09/05/24 | 50.24 on 09/05/24 |
| 1-Month | |||||
| %Chg | +7.35% since 08/09/24 | +2.32% since 08/09/24 | +0.90% since 08/09/24 | +1.34% since 08/09/24 | +4.00% since 08/09/24 |
| Low | 0.4500 on 09/06/24 | 317.93 on 08/12/24 | 1,109.99 on 08/12/24 | 458.04 on 08/13/24 | 46.48 on 08/12/24 |
| High | 0.6500 on 08/19/24 | 335.66 on 08/30/24 | 1,211.20 on 08/27/24 | 500.25 on 08/30/24 | 50.75 on 09/04/24 |
| 3-Month | |||||
| %Chg | -45.82% since 06/11/24 | +9.74% since 06/11/24 | +12.95% since 06/11/24 | -1.41% since 06/11/24 | +12.95% since 06/11/24 |
| Low | 0.4500 on 09/06/24 | 295.30 on 06/13/24 | 1,009.15 on 06/12/24 | 458.04 on 08/13/24 | 39.35 on 07/05/24 |
| High | 0.9400 on 06/12/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | -70.01% since 03/11/24 | +19.84% since 03/11/24 | +18.35% since 03/11/24 | +14.54% since 03/11/24 | -10.61% since 03/11/24 |
| Low | 0.4500 on 09/06/24 | 260.68 on 04/19/24 | 875.22 on 04/26/24 | 391.01 on 04/18/24 | 39.35 on 07/05/24 |
| High | 1.9400 on 03/22/24 | 346.85 on 07/25/24 | 1,211.20 on 08/27/24 | 510.64 on 08/01/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,329 | 176,449,568 | 125,209,848 | 121,486,200 | 99,895,480 |
| Shares Outstanding, K | 9,018 | 536,435 | 110,186 | 258,053 | 2,027,100 |
| Annual Sales | 310,000 | 28,190,000,000 | 13,117,200,000 | 9,869,200,000 | 45,006,000,000 |
| Annual Net Income | -11,260,000 | 6,717,000,000 | 3,953,600,000 | 3,619,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 3,547,100,000 | 2,645,600,000 | 12,201,000,000 |
| Last Quarter Net Income | -3,770,000 | 746,000,000 | 1,432,300,000 | -3,593,600,000 | 1,680,000,000 |
| 60-Month Beta | 0.99 | 0.61 | 0.12 | 0.40 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 08/14/24 | 4.97 on 08/06/24 | 11.56 on 08/01/24 | -12.83 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 08/19/24 | 10/29/24 | 08/01/24 | 11/04/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 07/05/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.52 | 29.80 | 0.00 | 35.40 |